Shaping the future of healthcare

The IQVIA Institute conducts empirically rigorous, policy-relevant studies to improve the quality and cost-effectiveness of healthcare. The Institute and its academic advisory board include members from a variety of disciplines including pharmacy, medicine, law, economics, business, and public policy.

Recent projects include an examination of trends in prescription opioid use, global and U.S. pricing dynamics, antibiotic utilization and trends in the use of technology and innovation in healthcare.

Research Support
Human Data Science Research Collaborative
COVID-19 has raised urgent questions for health systems and stakeholders around the world. Answering them will take collaborative, imaginative, and interdisciplinary research.

For a limited time, IQVIA is waiving access fees to two data technology platforms for academic affiliated researchers to address the transformation of healthcare systems in the COVID-19 era.
Learn More

Research priorities

The IQVIA Institute welcomes proposals examining most aspects of healthcare, projects that are directly relevant to ongoing healthcare reform are of greatest interest. High-priority areas include

  • Comparative effectiveness
  • Drug utilization trends and expenditure
  • Real world practice
  • Geographic variations in care
doctors meeting with businesspeople
doctors meeting with businesspeople

Comparative Effectiveness Research

  • Evaluations of which interventions work best, for whom, and under what circumstances
  • Analyses of how comparative effectiveness research is reflected in clinical practice
pharmacists hands taking medicines from shelf
pharmacists hands taking medicines from shelf

Drug Utilization Trends and Expenditures

  • Analysis of national trends in prescription drug utilization and office-based care
  • Examination of adoption of new therapies among patient and physician subpopulations
  • Evaluation of prescription use and expenditures and factors that influence these trends
pediatrician evaluating girl
pediatrician evaluating girl

Real-World Practice

  • Analysis of association between patient, physician, and health system characteristics and practice patterns
  • Establishment of best practices and quality metrics for specific conditions or populations, including for preventive care and screening
  • Utilization trends and costs in specific medical areas, such as oncology, cardiovascular disease or rare diseases where orphan drugs or specialty drugs are used
  • Investigations of socioeconomic, racial, or ethnic disparities in processes or outcomes of care
new york city aerial view
new york city aerial view

Geographic Variations in Care

  • Examination of geographic variations in treatments, costs and outcomes
  • Ecologic studies examining how geographic variation in prescription use (e.g., antibiotics) is associated with specific outcomes (e.g., antimicrobial resistance)
  • Studies using geographic variation in use to infer information regarding disease or treatment prevalence

Access to data and analysis

Through collaboration with the IQVIA Institute, researchers and students have access to a broad range of proprietary databases and tools to support independent research, discovery work and requirement development for future funded studies.

close-up of data pattern
close-up of data pattern

IQVIA Real World Data

  • De-identified patient activity across healthcare channels including Prescription Claims (retail and mail), Medical Claims, Hospital EMR, Health Plan, Consumer Behavior
  • 300+ million anonymous patients
  • Data available starting with the early 2000’s
  • Data can be linked (for example Prescription Claims and Medical claims) via the unique non-identified patient I.D
dispensing capsules
dispensing capsules

IQVIA Prescription Drug Data

  • Over 90% coverage for dispensed prescriptions
  • National views and sub-national views to state, county, zip code or prescriber granularity
  • Retail, mail and long-term care channels
  • Age, gender, co-pay, method of payment and payer details
Working and analyzing data figures
Working and analyzing data figures

IQVIA OneKey Reference Assets

  • Organization and professional reference data
  • Includes NPI, AMA, SLN, DEA, and AOA
  • Over 600,000 organizations and >8.9Mil professionals (~2.1mil prescriber eligible)
  • Includes physicians, nurse practioners and physician assistants
  • Includes ACOs, IDNs and affiliations
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

IQVIA Institute Inquiries

We are ready to help you better understand and benefit from the work of the IQVIA Institute for Human Data Science. Please get in touch today to learn more.